₹ 2.53
-0.01 (-0.39%)
BSE
T
Transgene Biotek
₹ 2.53
BSE
Transgene Biotek EPS Summary (consolidated)
The latest quarterly EPS of Transgene Biotek as of Q1 Jun 2026 stands at ₹-0.05. This is a 16.67% growth quarter on quarter and 16.67% growth same quarter last year. For the FY2026 the EPS of Transgene Biotek stands at ₹-0.22. This is a 144.44% fall compared with FY2025.
Transgene Biotek EPS
EPS by Peers

A
Apollo Hospitals

M
Max Healthcare Institute

A
Aster DM Quality Care

F
Fortis Healthcare

N
Narayana Hrudayalaya
*Based on consolidated figures.

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App

